Open-label, phase IIIb, multicenter, expanded access study of everolimus in patients with advanced neuroendocrine tumors (NET).
Oliver Edgar Bechter
No relevant relationships to disclose
Nicole Unger
No relevant relationships to disclose
Ivan Borbath
No relevant relationships to disclose
Sergio Ricci
No relevant relationships to disclose
Tsann-Long Hwang
No relevant relationships to disclose
Young Suk Park
No relevant relationships to disclose
Jiri Tomasek
No relevant relationships to disclose
Hussein Raef
No relevant relationships to disclose
Sudsawat Laohavinij
Research Funding - Novartis
Lisa JeanLouis
Employment or Leadership Position - Novartis
Ashok Panneerselvam
Employment or Leadership Position - Novartis
Stephen Saletan
Employment or Leadership Position - Novartis
Sotirios G. Stergiopoulos
Employment or Leadership Position - Novartis
Marianne E. Pavel
Consultant or Advisory Role - Ipsen; Novartis; Pfizer
Honoraria - Ipsen; Novartis; Pfizer